Cargando…
A brand new era of cancer immunotherapy: breakthroughs and challenges
Immunotherapy has opened a new era in cancer treatment. Drugs represented by immune checkpoint inhibitors have led to important breakthroughs in the treatment of various solid tumors, greatly improving the survival rate of cancer patients. Many types of immunotherapeutic drugs have become widely ava...
Autores principales: | Bai, Ri-Lan, Chen, Nai-Fei, Li, Ling-Yu, Cui, Jiu-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183825/ https://www.ncbi.nlm.nih.gov/pubmed/34039862 http://dx.doi.org/10.1097/CM9.0000000000001490 |
Ejemplares similares
-
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges
por: Pappas, Evan G., et al.
Publicado: (2023) -
Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer
por: Li, Wen-Qian, et al.
Publicado: (2020) -
Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021) -
A brand-new era has begun for JECT
por: Wong, Raymond K
Publicado: (2023) -
Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment
por: Yang, Ling, et al.
Publicado: (2022)